GeoPharma, Inc. Completes Recapitalization and Restructuring
August 05, 2010 12:01 ET
|
GeoPharma, Inc.
LARGO, Fla., Aug. 5, 2010 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Pink Sheets:GORX) today announced that, on Monday August 2, 2010, the Company completed a recapitalization and restructuring designed to...
GeoPharma Reduces Senior Convertible Debt
April 21, 2010 10:30 ET
|
GeoPharma, Inc.
LARGO, Fla., April 21, 2010 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that since December 31, 2009, it has reduced its 12% convertible debt (the "Debt") owed to...
GeoPharma Announces the Acceptability of Their Largo Cephalosporin Plant
March 02, 2010 11:27 ET
|
GeoPharma, Inc.
LARGO, Fla., March 2, 2010 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that the FDA Office of Compliance has completed the evaluation of its Largo, Florida...
GeoPharma Announces Fiscal Year 2010 Third Quarter Results Conference Call
March 01, 2010 13:27 ET
|
GeoPharma, Inc.
LARGO, Fla., March 1, 2010 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") is hosting a conference call on March 2, 2010 at 11 a.m. ET to discuss the Fiscal Year 2010 Third Quarter...
GeoPharma Announces Fiscal Year 2010 Third Quarter Results and Conference Call
February 23, 2010 07:55 ET
|
GeoPharma, Inc.
LARGO, Fla., Feb. 23, 2010 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today the results of its fiscal year 2010 third quarter which ended December 31, 2009, with...
GeoPharma Receives Guidance From NASDAQ Regarding Minimum Stockholders' Equity Requirement
December 03, 2009 08:30 ET
|
GeoPharma, Inc.
LARGO, Fla., Dec. 3, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today it received a NASDAQ Staff Deficiency Letter on November 25th, 2009 indicating that the...
GeoPharma Announces Fiscal Year 2010 Second Quarter Results and Conference Call
November 24, 2009 06:55 ET
|
GeoPharma, Inc.
LARGO, Fla., Nov. 24, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today the results of its fiscal year 2010 second quarter which ended September 30, 2009, with...
GeoPharma Receives Guidance From NASDAQ Regarding Minimum Bid Price Requirement
September 18, 2009 18:00 ET
|
GeoPharma, Inc.
LARGO, Fla., Sept. 18, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today it received a Nasdaq Staff Deficiency Letter on September 15th, 2009 indicating that the...
GeoPharma Announces Settlement of Baltimore Beta-Lactam Antibiotics Facility Litigation
September 08, 2009 07:00 ET
|
GeoPharma, Inc.
LARGO, Fla., Sept. 8, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that it, through its subsidiary, American Antibiotics, LLC (collectively, "AA Parties") has...
GeoPharma Announces Fiscal Year 2010 First Quarter Results and Conference Call
August 17, 2009 07:00 ET
|
GeoPharma, Inc.
LARGO, Fla., Aug. 17, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today the results of its fiscal year 2010 first quarter.
Commenting on the quarter GeoPharma...